Post-AD/PD 2022 Webinar and Q&A: Simoa® Highlights



Join us as our Field Applications Scientist Danilo La Terra presents some of the Simoa® highlights of AD/PD 2022.

Hear about how phosphorylated Tau 181, GFAP, NfL and others are being measured in blood to transform the way we identify patients with Alzheimer‘s Disease. We will also cover how Simoa® ultra-sensitive assays work, as well as the performance of our key assays for Alzheimer’s Disease, including phosphorylated Tau and our multiplex assays. 

By submitting this form, you agree to Quanterix’s Terms of Use and Privacy Policy. In addition, you agree to receive information regarding Quanterix products and services. You will be able to unsubscribe at any time.